Looking Into the Future of Drug Development for Chronic Upper Gastrointestinal Symptoms and Related DiseasesCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122024-12-011OAAI
Environmental Toxins in Breast Milk and Risk of Early Onset Colorectal Cancer ReplyCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122024-06-010OAAI
Patient Satisfaction From Up-Front Endoscopy in the Evaluation of Uninvestigated Dyspepsia: At What Cost? ReplyCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122023-11-010PRE
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia ReplyCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122023-10-010OA
Uninvestigated Dyspepsia: To Scope or Not to Scope? ReplyCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122023-10-010OA
Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost- Satisfaction in Uninvestigated DyspepsiaCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122023-08-0114PRE
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndromeALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72022-08-071OAAI
Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment OptionsDRUGSIF14.42021-11-0210PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向